drugset / Trial / NCT07706777

Clinical Study of HRS-2129 for Acute Gouty Arthritis

NCT07706777

Phase 2 Not yet recruiting 90 enrolled Shandong Suncadia Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.

Timeline

Start
2026-07
Primary completion
2026-10
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-2129 Unknown

Indications